“We had a strong start to the year with earnings growth and margin expansion despite total revenue being essentially flat, underscoring the resilience of the business,” Adam Grossman (Co-Founder, ...

Adma Biologics (ADMA) closed the most recent trading day at $8.97, moving 1.21% from the previous trading session.

Adma Biologics (ADMA) closed the most recent trading day at $8.59, moving -1.83% from the previous trading session. This move lagged the S&P 500's daily gain of 0.89%. Elsewhere, the Dow gained 0.74%, ...

ADMA Biologics stock has delivered a very large 5 year return while its broader valuation checks still point to the shares ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities betwee ...

Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of $40 Million in 4Q 2025 2026 Expected to be ADMA's First Full Year of Yield-Enhanced Production, ...

ADMA Biologics draws attention as plasma demand, vertical integration, legal risk, and defensive healthcare trends shape its ...

The MarketWatch News Department was not involved in the creation of this content. Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business ...

These stocks are better bets to skyrocket than the much-hyped rocket stock.

Learn more about whether ADMA Biologics, Inc. or CareDx, Inc. is a better investment based on AAII's A+ Investor grades, ...